inflammation and glp 1 Impact of GLP-1 on different immune cells. GLP-1 induces a stage of Glucagon-like peptide 1(GLP-1) receptor agonists

The United States anchors regional demand, with uptake concentrated among young professionals, and wellness-focused consumers who view yerba mate as a cleaner, plant-based alternative to coffee and conventional energy drinks

PPAR agonists: emergent therapy in endometriosis

10

Asia Pacific Expected to Record the Highest CAGR The Asia Pacific region is projected to register the fastest CAGR during the forecast period, driven by the rapidly rising incidence of type 2 diabetes and increasing healthcare investments

As of October 2025, 12 GLP-1 therapies have been approved for indications in Type 2 diabetes and/or obesity, per the guidance